Combination therapy with indacaterol and glycopyrronium bromide in the management of COPD: an update on the evidence for efficacy and safety [PDF]
Therapeutic Advances in Respiratory Disease, 2015 The international guidelines on chronic obstructive pulmonary disease (COPD) recommend inhaled bronchodilators for maintenance treatment of the disease. These drugs include β2-agonists and muscarinic antagonists, which are both available as short-acting ...
Erminia Ridolo +4 more
doaj +2 more sources
Effects of long-term bronchodilators in bronchiectasis patients with airflow limitation based on bronchodilator response at baseline [PDF]
International Journal of COPD, 2016 Ho Jung Jeong,1,* Hyun Lee,1,* Keumhee C Carriere,2,3 Jung Hoon Kim,1 Jin-Hyung Han,1 Beomsu Shin,1 Byeong-Ho Jeong,1 Won-Jung Koh,1 O Jung Kwon,1 Hye Yun Park1 1Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical ...
Jeong HJ +9 more
doaj +1 more source
An update on the use of indacaterol in patients with COPD [PDF]
Therapeutic Advances in Respiratory Disease, 2011 Current guidelines for the management of chronic obstructive pulmonary disease (COPD) establish that bronchodilator medications are central to the symptomatic treatment of the disease.
Nadia S. Brienza +2 more
doaj +2 more sources
Bronchodilator effect on regional lung function in pediatric viral lower respiratory tract infections [PDF]
, 2022 Objective: Viral lower respiratory tract infections (LRTI) are the leading cause for acute admission to the intensive care unit in infants and young children. Nebulized bronchodilators are often used when treating the most severe cases.
Richard H Bayford +17 more
core +4 more sources
Role of combined indacaterol and glycopyrronium bromide (QVA149) for the treatment of COPD in Japan [PDF]
International Journal of COPD, 2015 Nobuyuki Horita, Takeshi Kaneko Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan Abstract: Once-daily dual-bronchodilator therapy with combined indacaterol and glycopyrronium bromide in one device ...
Horita N, Kaneko T
doaj +1 more source
The Ideal Bronchodilator [PDF]
, 1979 From the clinician's standpoint, an ideal bronchodilator should have (1) selectivity for bronchial smooth muscle, (2) minimal stimulatory effects on the cardiovascular and central nervous system, (3) prolonged action, (4) rapid onset of action, and (5 ...
Wanner, Adam, Adam Wanner
core +1 more source
The effect of oral corticosteroids on bronchodilator responses in COPD [PDF]
, 1998 There have been suggestions that corticosteroid treatment might improve bronchodilator responses in chronic obstructive pulmonary disease (COPD). We have studied bronchodilator responses to salbutamol and to oxitropium bromide in 20 patients with stable ...
Rees, P.J., Corden, Z.
core +1 more source
, 2023 Factors were studied which determine bronchodilator response to different agents in patients with suspected asthma or ...
Zsofia Lazar (17101969)
core +1 more source
An acute bronchodilator test with tiotropium or salmeterol does not allow a subdivision of patients according to responses [PDF]
, 2005 The possibility that individual chronic obstructive pulmonary disease (COPD) patients respond better to either tiotropium or salmeterol has been suggested and an acute bronchodilator test might help to guide the choice of therapy.
CAZZOLA M. +5 more
core +3 more sources
Paediatrics: how to manage acute asthma exacerbations
Drugs in Context, 2021 Background: Asthma is the most common chronic disease of childhood and a major source of childhood health burden worldwide. These burdens are particularly marked when children experience characteristic ‘symptom flare-ups’ or acute asthma exacerbations ...
James S Leung
doaj +1 more source